Globeflex Capital’s Impax Laboratories, Inc. IPXL Stock Holding History

Globeflex Capital’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-46,400	Closed	-$587K	–	498
2017 Q1	$587K	Hold	46,400	–	–	0.14%	246
2016 Q4	$615K	Buy	+46,400	New	+$793K	0.15%	229
2015 Q2	–	Sell	-59,563	Closed	-$2.79M	–	632
2015 Q1	$2.79M	Sell	59,563 -12,120	-17%	-$482K	0.53%	33
2014 Q4	$2.27M	Buy	71,683 +26,712	+59%	+$782K	0.44%	64
2014 Q3	$1.07M	Sell	44,971 -2,729	-6%	-$69.9K	0.12%	195
2014 Q2	$1.43M	Hold	47,700	–	–	0.16%	165
2014 Q1	$1.26M	Buy	47,700 +18,600	+64%	+$465K	0.14%	174
2013 Q4	$731K	Buy	+29,100	New	+$649K	0.09%	252

Other funds holding IPXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Globeflex Capital's IPXL Position: Q2 2017 in Review

Globeflex Capital sold out of Impax Laboratories, Inc. (IPXL) in Q2 2017, closing a stake of 46,400 shares — an estimated $587K sold.

Globeflex Capital first reported a position in IPXL in Q4 2013 and held it in 8 quarters. The position peaked at $2.79M in Q1 2015. 172 funds tracked by Wall St. Rank hold IPXL as of Q2 2017.

Globeflex Capital reported no remaining Impax Laboratories, Inc. position as of Q2 2017 after selling out during the quarter.
Globeflex Capital sold 46,400 Impax Laboratories, Inc. shares in Q2 2017, an estimated $587K.
Globeflex Capital first reported a position in Impax Laboratories, Inc. in Q4 2013 and held it in 8 quarters.
Globeflex Capital's Impax Laboratories, Inc. position peaked at $2.79M in Q1 2015.
172 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2017.

Based on Globeflex Capital's 13F filing for Q2 2017, filed 11 Aug 2017.